4510 Executive Drive
BIOCOM is the largest regional life science association in the world, representing more than 550 member companies in Southern California across all major life science sectors, including biotechnology, pharmaceutical, diagnostic, medical device, connected health and biorenewables. The association focuses on initiatives that positively influence the region’s life science community in the development and delivery of innovative products that improve health and quality of life. BIOCOM provides a tremendous range of initiatives and programs in public policy, capital access, group savings, professional network building and talent development. For more information on BIOCOM or the Southern California life science community, please click around our site (www.biocom.org) or call (858) 455-0300.
• Joseph D. Panetta, President and CEO
• Jennifer Landress, Sr. VP and Chief Operating Officer
• Rick Fultz, VP Business Development BIOCOM, Managing Director BIOCOM Purchasing Group
130 articles with Biocom
10/2/2020Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.
Biocom, the association representing the life science industry of California, today announced the appointment of Stephanie Hsieh as the organization’s executive director for its Los Angeles office, effective immediately. “Steph is an accomplished biotech executive with deep industry knowledge t
Biocom, the association representing the California life science industry, announced the appointment of Randy Piper as managing director for the Biocom Purchasing Group, a subsidiary of Biocom that accelerates life science success by leveraging innovative, member-driven strategic sourcing solutions that significantly lower the total cost of doing business.
Leading State Life Sciences Associations Express Concerns with CMS’ Rule on Medicaid Value-Based Agreements
BioNJ, Biocom, the California Life Sciences Association, the HINJ, LSPA, and the Michigan Biosciences Industry Association submitted comments to the CMS on a notice of proposed rulemaking impacting value-based purchasing agreements and other innovative solutions designed to provide patient access to, and purchasing agreements for, cutting edge therapies and cures.
Biocom Supports California Life Science Companies with Best Practices Guide for Safely Returning to the Workplace
Newly Available Publication Synthesizes Relevant Guidance from Multiple Federal and State Agencies
Feb. 10, 2020 15:00 UTC The Digital MedTech Conference to showcase the growing and evolving digital medtech landscape WASHINGTON & SAN DIEGO--( BUSINESS WIRE )-- The Advanced Medical Technology Association (AdvaMed) and Biocom, the association representing the California life science industry, today announced a joint partnership to collaboratively produce The Digital MedTech Conference 2020. In combining Biocom’s DeviceFest and Digital Health Conference with AdvaMed’s D
Biocom, the association representing the life science industry of California, issued the following statement regarding the passage of H.R.3, the Lower Drug Costs Now Act, in the House of Representatives today
Biocom Expresses Strong Concerns Over New USMCA Agreement Removing Essential Protections for Life-Saving Drugs
Biocom, the association representing the life science industry of California, issued the following statement in response to the revised United States-Mexico-Canada Agreement deal unveiled yesterday by the Trump Administration.
In this role, she will oversee strategies, programs and staff and drive initiatives focused on STEM education and workforce development.
New Data: Foreign Reference Pricing Proposal in H.R. 3 Would Slash Life-Saving R&D and Lead to Destruction of California’s Life Sciences Sector
CLSA and Biocom Release Data Showing Anticipated Real-World Impact of Foreign Reference Pricing Proposed by House Democrats in H.R. 3 to Lower Drug Prices
Biocom, the association representing the California life science industry, today announced the winners of its Fourth Annual Catalyst Awards
Judy Chou, Ph.D., senior vice president and global head of biotech/Berkeley site head, Bayer, Emad Fareed, partner at KPMG, and Bob Ramos, partner at Procopio, to its board of directors.
California is well-known for its position in the biotech and pharma industry, with two world-class hubs in the Bay Area and the San Diego region. However, a new survey reveals the state is actually home to three significant hubs.
Biocom, the association representing the California life science industry, today announced that it has added Matt Abernethy, chief financial officer of Neurocrine Biosciences, and Sabrina Martucci Johnson, president and chief executive officer of Daré Biosciences, to its board of directors.
BioLA was founded in 2018 to ensure Los Angeles has a collaborative, well-coalesced ecosystem that encompasses all aspects of the Southern California life sciences cluster.
California’s life science sector is a major player in the state’s job creation and economic development. In 2016, life science companies in California employed more than 360,000 professionals.
Biotech companies need more than just researchers to ensure success. The most recent 2018 Talent Report issued by Biocom shows that 88 percent of California life science companies are planning on hiring over the next 12 months.
Biocom, the association representing the life science industry of California, and The CO Network, a culture technology company, today announced that they are hosting the 3rd Annual Big Data Summit at The Alexandria at Torrey Pines on Tuesday, November 6, 2018 from 8:15 am to 7:00 pm.
Biocom, the association representing the life science industry of California, today applauded the introduction of H.R. 6801, the Rare Disease (RaD) Fund Act by U.S. Representatives Juan Vargas (D-CA), Scott Peters (D-CA) and Tom Rooney (R-FL).
Biocom, the association representing the California life science industry, today announced the formation of a San Francisco Bay Area advisory board, as well as the grand opening of its Bay Area office.